Patents Assigned to Helmholtz Zentrum Fur Infektionsforschung GMBH (HZI)
  • Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism
    Publication number: 20110118317
    Abstract: The present invention is about the use of at least one epothilone or derivative thereof as an active ingredient for manufacturing a medicament for use in the treatment of disease(s) involving a neuronal connectivity defect.
    Type: Application
    Filed: September 9, 2010
    Publication date: May 19, 2011
    Applicants: Institut National de la Sante et de la Recherche Medicale (INSERM), Commissariat a l'Energie Atomique (CEA), Helmholtz Zentrum Fur Infektionsforschung GMBH (HZI)
    Inventors: Annie Andrieux, Didier Job, Annie Schweitzer, Gerhard Höfle